Inventor · disambiguated record
Laura Silvian
Also filed as: SILVIAN LAURA · SILVIAN LAURA F
10 granted patents·5 pending applications·106 citations·filing 2000–2023
90Inventor score
Files withBIOGEN IDEC INC3BIOGEN MA INC2ROSSOMANDO ANTHONY2SUNESIS PHARMACEUTICALS INC2VIRACTA THERAPEUTICS INC2
Top patents by PatentIndex Score
15 records- 0192US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0292US7442370B2Polymer conjugates of mutated neublastinBIOGEN IDEC INC·Filed 2003·Granted Oct 28, 2008·35 cites·68 claims
- 0391US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 0489US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 0587US8669345B2Nogo receptor antagonistsLEE DANIEL H S·Filed 2007·Granted Mar 11, 2014·16 cites·3 claims
- 0685US8119114B2Polymer conjugates of mutated neublastinSAH DINAH WEN-YEE·Filed 2008·Granted Feb 21, 2012·3 cites·60 claims
- 0784US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0882US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 0978US8263553B2Neublastin variantsROSSOMANDO ANTHONY·Filed 2005·Granted Sep 11, 2012·3 cites·219 claims
- 1078US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1176US9228015B2Nogo receptor antagonists and methods of increasing neurite outgrowthBIOGEN IDEC INC·Filed 2014·Granted Jan 5, 2016·2 cites·5 claims
- 1275US6631329B1Use of the crystal structure of Staphylococcus aureus isoleucyl-tRNA synthetase in antibiotic designUNIV YALE·Filed 2000·Granted Oct 7, 2003·5 cites·23 claims
- 1370US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1448US2016159878A1NOGO Receptor AntagonistsBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 1547US2013096065A1Neublastin variantsROSSOMANDO ANTHONY·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →